Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
NCT01286909
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Metabolic Disease
Interventions
DIETARY_SUPPLEMENT:
LaFlavon
Sponsor
Omicron Pharmaceuticals